Tobacco, Cannabis Use Tied to High Rates of Self-Reported Mental Health Issues

FRIDAY, Sept. 15, 2023 (HealthDay News) -- Use of tobacco and/or cannabis, particularly co-use of both substances, is associated with poor mental health, according to a study published online Sept. 13 in PLOS ONE.
Nhung Nguyen, Ph.D., from the University of California, San Francisco, and colleagues used data from the digital COVID-19 Citizen Science Study (2020 to 2022) to examine associations between self-reported use of tobacco and/or cannabis with anxiety and depression.
The researchers found that compared with nonuse, the adjusted odds of mental health disorders were highest for co-use (odds ratios [95 percent confidence intervals], 1.89 [1.64 to 2.18] and 1.77 [1.46 to 2.16] for anxiety and depression, respectively). Co-use (odds ratio, 1.35; 95 percent confidence interval, 1.08 to 1.69) and cannabis-only use (odds ratio, 1.17; 95 percent confidence interval, 1.00 to 1.37) were associated with higher adjusted odds for anxiety, but not for depression, compared with tobacco-only use. There were higher adjusted odds for both anxiety and depression associated with daily use (versus nondaily use) of cigarettes, e-cigarettes, and cannabis.
"The findings suggest that coordinating tobacco and cannabis cessation with mental health treatment may be beneficial to address these comorbidities," the authors write. "Specifically, providing mental health support and addressing polysubstance use (e.g., tobacco, cannabis, alcohol) among individuals with co-use are needed to facilitate successful cessation from tobacco and cannabis."
Related Posts
Use of Proton Beam Therapy for Newly Diagnosed Cancer on the Rise
FRIDAY, May 6, 2022 (HealthDay News) -- The number of U.S. patients receiving...
Casi 59,000 trabajadores cárnicos contrajeron la COVID, y 269 murieron, según un informe
JUEVES, 28 de octubre de 2021 (HealthDay News) -- El número de trabajadores de...
Wegovy May Be Valuable New Option for Heart Failure Patients
FRIDAY, Aug. 25, 2023 (HealthDay News) -- Weight-loss drug Wegovy (semaglutide)...
Blinded by Chemical Burns, Patients Regained Sight With New Stem Cell Therapy
FRIDAY, Aug. 18, 2023 (HealthDay News) -- Phillip Durst was working near an...
